The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 28, 2025
Filed:
Aug. 20, 2019
Applicant:
Ucl Business Ltd, London, GB;
Inventors:
Amit Nathwani, London, GB;
Jenny Mcintosh, London, GB;
Assignee:
UCL Business LTD, London, GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 31/573 (2006.01); A61P 7/00 (2006.01); C07K 14/81 (2006.01); C12N 7/00 (2006.01); C12N 9/64 (2006.01); G01N 33/49 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/644 (2013.01); A61K 31/573 (2013.01); C12N 7/00 (2013.01); G01N 33/4905 (2013.01); A61K 38/00 (2013.01); C12N 2750/14142 (2013.01); C12N 2750/14143 (2013.01); C12N 2830/008 (2013.01); C12N 2830/50 (2013.01); C12Y 304/21022 (2013.01); G01N 2333/9645 (2013.01);
Abstract
The present invention relates to polynucleotides comprising a Factor IX nucleotide sequence, wherein the Factor IX nucleotide sequence comprises a coding sequence that encodes a Factor IX protein or fragment thereof and wherein a portion of the coding sequence is not wild type. The present invention further relates to viral particles comprising a recombinant genome comprising the polynucleotide of the invention, compositions comprising the polynucleotides or viral particles, and methods and uses of the polynucleotides, viral particles or compositions.